- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01654666
Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting
Study Overview
Status
Conditions
Detailed Description
BACKGROUND: Brain ischemia and injury contributed to perioperative morbidity and mortality in Carotid Artery Stenting. Remote ischemic preconditioning (RIPC), brief periods of ischemia followed by reperfusion, can provide systemic protection for prolonged ischemia. Our previous study found no significant protection to the patients who received once RIPC before Carotid Artery Stenting. In order to investigate whether long-term RIPC before Carotid Artery Stenting can protect these patients from the perioperative and long-term complications, a prospective randomized controlled trial will be performed in the current study.
DESIGNING: About 189 patients who are eligible for carotid artery stenting will be randomly assigned in 1:1:1 ratio to RIPC group, sham RIPC group and conventional Carotid Artery Stenting group (control). Remote limb ischemic preconditioning (RIPC) is consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, it is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min, patients in the RIPC group will do it twice a day for at least two weeks before carotid artery stenting. Patients in the sham RIPC group receive sham RIPC treatment, which is consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min, they will do it twice a day for at least two weeks before carotid artery stenting. Patients in the control group receive conventional carotid artery stenting without RIPC or sham RIPC treatment. Cerebral injury is assessed by serum S-100B and Neuron specific enolase (NSE), systematic inflammation is assessed by serum high-sensitivity C-reactive protein (hs-CRP). Post-treatment infarctions, both symptomatic and asymptomatic, are detected by diffusion-weighted imaging (DWI) and clinical outcomes are determined by cerebrovascular events, cardiac events or death.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100053
- Baojun Hou
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Symptomatic or asymptomatic carotid artery stenosis. In symptomatic patients the degree of stenosis should more than 60% (Based on NASCET Criteria), in asymptomatic patients the degree of stenosis should more than 70% (Based on NASCET Criteria);
- Tolerance to any of the study medications, including clopidogrel, aspirin and statins;
- Can cooperate with and complete brain MRI examination;
- Has a negative pregnancy test within 7 days before randomization and no childbearing potential;
- Vascular ultrasound excluded intravascular thrombosis and unstable plaques in blood vessels of the bilateral upper limbs;
- No hemorrhagic tendency;
- Stable vital sign, normal renal and hepatic functions;
- Informed consent.
Exclusion Criteria:
- Evolving stroke;
- Prior major ipsilateral stroke, if likely to confound study endpoints;
- Severe dementia;
- Hemorrhagic conversion of an ischemic stroke within the past 60 days;
- Chronic atrial fibrillation;
- Myocardial infarction within previous 30 days;
- Inability to understand and cooperate with study procedures or provide informed consent;
- Participating in other device or drug trial that has not completed the required protocol follow-up period;
- Any conditions that hampers proper angiographic assessment or makes percutaneous arterial access unsafe;
- High risk candidates defined as the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST);
- Any vascular, extremity soft tissue or orthopedic injury that may contraindicate bilateral arm ischemic preconditioning (e.g. superficial wounds and fractures of the arm);
- Blood pressure cannot be controlled lower than 200 mmHg by medications;
- Peripheral blood vessel disease (especially subclavian arterial and upper limb artery stenosis or occlusion).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: RIPC group
Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment. Device:RIPC consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min,each patient in the RIPC group do it twice a day for at least two weeks before carotid artery stenting. Procedure: Carotid Artery Stenting |
Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Other Names:
Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.
Other Names:
|
ACTIVE_COMPARATOR: Control group
Treatment:Patients in this group received standard medical therapy alone.
Procedure: Carotid Artery Stenting
|
Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.
Other Names:
|
SHAM_COMPARATOR: Sham RIPC group
Treatment:Patients in this group received standard medical therapy and sham remote ischemic preconditioning treatment. Device:Sham RIPC consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min, each patient in RIPC group do it twice a day for at least two weeks before carotid artery stenting. Procedure: Carotid Artery Stenting |
Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.
Other Names:
Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients With Cerebrovascular Events, Cardiovascular Events or Death.
Time Frame: Within six months after carotid artery stenting
|
Cerebrovascular events included ischemic stroke, transient ischemic attack (TIA), cerebral hemorrhage and hyperperfusion syndrome.
Cardiovascular events included angina and myocardial infarction.Death included any reason caused death.
|
Within six months after carotid artery stenting
|
Participants Who Got New Diffusion-weighted Imaging (DWI) Lesions on Post-treatment Magnetic Resonance Imaging (MRI) Scans.
Time Frame: Within 48 hours after carotid artery stenting.
|
Within 48 hours after carotid artery stenting.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum High-sensitive C-reactive Protein (Hs-CRP).
Time Frame: Baseline, on admission, and 1 and 24 hours after carotid artery stenting.
|
Baseline, on admission, and 1 and 24 hours after carotid artery stenting.
|
|
Number of Patients With Any Side Effects of Remote Ischemic Preconditioning (RIPC) Treatment.
Time Frame: From baseline to 6 months after treatment.
|
The side effects referred to any side effects of RIPC or sham RIPC treatment, not including the sides effect of medications and CAS.
|
From baseline to 6 months after treatment.
|
Serum Neuron Specific Enolase (NSE) Levels.
Time Frame: Baseline, on admission, and 1 and 24 hours after carotid artery stenting.
|
Baseline, on admission, and 1 and 24 hours after carotid artery stenting.
|
|
Serum S-100B Levels.
Time Frame: Baseline, on admission, and 1 and 24 hours after carotid artery stenting.
|
Baseline, on admission, and 1 and 24 hours after carotid artery stenting.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xunming Ji M.D., Ph.D., Capital Medical University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RIPC2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carotid Artery Stenosis
-
Heinrich-Heine University, DuesseldorfRecruitingCarotid Artery Plaque | Carotid Artery Diseases | Carotid Artery Stenosis Asymptomatic | Carotid Artery StenosisGermany
-
Xuanwu Hospital, BeijingChanghai Hospital; Peking Union Medical College Hospital; The Second Hospital... and other collaboratorsRecruitingCarotid Artery Stenting | Carotid Endarterectomy | Best Medical Treatment | Carotid Artery Stenosis AsymptomaticChina
-
Aesculap AGEnrolling by invitationCarotid Artery Stenosis | Iliac Artery Stenosis | Femoral Artery StenosisGermany
-
Xuanwu Hospital, BeijingRecruitingRadiation-induced Carotid Artery StenosisChina
-
Centre Hospitalier St AnneHôpitaux Universitaires Paris Ile-de-Franc OuestNot yet recruiting
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); Cedars-Sinai Medical Center and other collaboratorsRecruitingCarotid Atherosclerosis | Asymptomatic Carotid Artery Stenosis | Carotid Artery AtheromaUnited States
-
Mayo ClinicRecruitingPatients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery PlaqueUnited States
-
University of BolognaActive, not recruiting
-
W.L.Gore & AssociatesCompleted
-
Oslo University HospitalCompletedCarotid Artery Stenoses
Clinical Trials on Remote ischemic preconditioning
-
Tartu University HospitalCompletedAtherosclerosis | Stable Angina | Peripheral Artery Disease | Contrast-induced NephropathyEstonia
-
St. Francis Hospital, New YorkTerminatedCoronary Artery DiseaseUnited States
-
Capital Medical UniversityPeking University First HospitalCompletedCerebral Small Vessel DiseaseChina
-
Azienda Ospedaliera Città della Salute e della...CompletedAcute Kidney InjurySpain, France, Italy
-
Medical University of LodzCompletedRemote Ischemic Preconditioning | Contrast Induced - Acute Kidney InjuryPoland
-
Ulsan University HospitalCompletedContrast Induced Acute Kidney InjuryKorea, Republic of
-
Università Vita-Salute San RaffaeleRecruitingMyocardial Ischemia | SurgeryItaly, Russian Federation, Serbia
-
St. Josefs-Hospital Wiesbaden GmbHRecruitingAtrial FibrillationGermany
-
Institut für Pharmakologie und Präventive MedizinWithdrawnEffectivity of RIPC in Outcomes of TAVI ProcedureGermany